Hovid shares drop due to revocation of licences


The licence, given yesterday, enables the company to resume its operations

PETALING JAYA: Shares of Hovid Bhd fell to a low of 24 sen yesterday, as investor sentiment was hit by the Health Ministry’s move to repeal the manufacturing licences for both of the company’s facilities in Perak.

The healthcare and pharmaceutical company ended at 30 sen, down 4.5 sen at the close.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Hovid , license , manufacturers

   

Next In Business News

Ringgit ends firmer against US dollar
KPJ Healthcare partners with Trustr for AI-driven healthcare solutions
Homeritz stays positive amid economic challenges
Unisem expects performance boost amid semiconductor recovery
Gadang wins RM280mil data centre contract
S P Setia unveils Casaville single-storey bungalows in Setia EcoHill, Semenyih
FBM KLCI rebounds to hit fresh two-year high
Asian FX subdued after mixed US data; equities set for weekly gains
Global manufacturing activity recovery to continue gradually into 2024 - S&P Global
Country Garden plans to present debt revamp plan in second half, sources say

Others Also Read